A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

Starting soon · Phase 1 · Has a placebo group

Conditions studied: Non-small Cell Lung Cancer (NSCLC), Cachexia

In brief

Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung cancer associated cachexia.

Key facts

Study ID

NCT07663630

Run by

Pfizer

People needed

80

Starts

2026-07-22

Expected to finish

2029-03-29

Last updated by the study team

2026-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.